Effects of sterigmatocystin on esophageal epithelium and experimental reflux esophagitis in rats

Tong,Pan-Zhuo; Zhang,Guo-Jian; Zhang,Xiang-Hong; Yan,Xia; Wang,Jun-Ling

doi:10.3892/mmr.2013.1631

Effects of sterigmatocystin on esophageal epithelium and experimental reflux esophagitis in rats

Authors:
- Pan-Zhuo Tong
- Guo-Jian Zhang
- Xiang-Hong Zhang
- Xia Yan
- Jun-Ling Wang
View Affiliations

Affiliations: Department of Pathology, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, Department of Surgery, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China
Published online on: August 14, 2013 https://doi.org/10.3892/mmr.2013.1631
Pages: 1043-1048

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Patients with reflux esophagitis experience an increased incidence of esophageal cancer. In China, this may be the result of contamination of the food supply by Aspergillus fungi, which is known to harbor sterigmatocystin, a carcinogenic mycotoxin. To delineate the potential link between sterigmatocystin and esophageal cancer, an experimental model of reflux esophagitis was developed in rats that had undergone a cardiectomy and partial pylorus ligation. The rats were treated with sterigmatocystin or saline, and esophageal squamous cell hyperplasia was assessed based on the pathological evaluation. The expression of proliferating cell nuclear antigen (PCNA), transporter associated with antigen processing 1 (TAP1) and low molecular weight protein 2 (LMP2) was determined by immunohistochemistry. Intraperitoneal administration of sterigmatocystin promoted the proliferation of squamous epithelium. In addition, it also increased the expression of PCNA in esophageal epithelial cells in rats with reflux esophagitis and was correlated with the increased severity of epithelial hyperplasia. The expression levels of TAP1 and LMP2, which are located in the cytoplasm of esophageal epithelial cells, were reduced in rats with reflux esophagitis, and sterigmatocystin exposure further decreased the expression. Thus, the downregulation of TAP1 and LMP2 proteins by sterigmatocystin may directly affect tumor immunity by allowing transformed cells to escape the host immune surveillance, thereby promoting esophageal cancer.

View Figures

View References

1	Zhang X, Wang F, Wang J, et al: Experimental lung carcinoma induced by fungi and mycotoxins - a review. Beijing Da Xue Xue Bao. 35:4–6. 2003.(In Chinese).
2	Versilovskis A and De Saeger S: Sterigmatocystin: occurrence in foodstuffs and analytical methods - an overview. Mol Nutr Food Res. 54:136–147. 2010. View Article : Google Scholar : PubMed/NCBI
3	Zhang XH and Xue LY: Carcinogenicity and biological effectiveness of sterigmatocystin. Zhonghua Bing Li Xue Za Zhi. 38:136–138. 2009.(In Chinese).
4	Xing LX, Zhang XH, Shen HT, et al: Experimental study on the carcinogenic effects of sterigmatocystin in new born BALB/c mice. Zhonghua Bing Li Xue Za Zhi. 36:265–266. 2007.(In Chinese).
5	Nakajima M, Kato H, Miyazaki T, et al: Tumor immune systems in esophageal cancer with special reference to heat-shock protein 70 and humoral immunity. Anticancer Res. 29:1595–1606. 2009.PubMed/NCBI
6	Abdel-Latif MM, Duggan S, Reynolds JV and Kelleher D: Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol. 9:396–404. 2009. View Article : Google Scholar : PubMed/NCBI
7	Xu JY, Zhang JK and Wang RM: Control observation on esophageal carcinoma and esophagitis detected by endoscopy between high and low incidence areas of esophageal carcinoma. Chin J Clin Gastroenterol. 7:101–103. 1995.(In Chinese).
8	Ho JA and Durst RA: Detection of fumonisin B1: comparison of flow-injection liposome immunoanalysis with high-performance liquid chromatography. Anal Biochem. 312:7–13. 2003. View Article : Google Scholar : PubMed/NCBI
9	Huang X, Zhang X, Yan X and Yin G: Effects of sterigmatocystin on interleukin-2 secretion of human peripheral blood mononuclear cells in vitro. Wei Sheng Yan Jiu. 31:112–114. 2002.(In Chinese).
10	Tong P, Zhang X, Yan X, Wang JL and Zhang GJ: Effects of sterigmatocystin on the expression of HLA class I in esophageal squamous cells in vitro. Chin J Exp Surg. 23:583–584. 2006.(In Chinese).
11	Yu ZL: Reflux esophagitis diagnostic criteria and the existing problems. J Chin Med. 39:151–152. 2000.(In Chinese).
12	Fiocca R, Mastracci L, Riddell R, et al: Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum Pathol. 41:223–231. 2010. View Article : Google Scholar
13	Yuan S and Brookes SJ: Neuronal control of the gastric sling muscle of the guinea pig. J Comp Neurol. 412:669–680. 1999. View Article : Google Scholar : PubMed/NCBI
14	Miller L, Dai Q, Vegesna A, et al: A missing sphincteric component of the gastro-oesophageal junction in patients with GORD. Neurogastroenterol Motil. 21:e813–e852. 2009. View Article : Google Scholar : PubMed/NCBI
15	Xu Z, Hu T and Liu W: A new procedure in making reliable experimental models of gastroesophageal reflux. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 18:288–290. 2004.(In Chinese).
16	Rohof WO, Hirsch DP and Boeckxstaens GE: Pathophysiology and management of gastroesophageal reflux disease. Minerva Gastroenterol Dietol. 55:289–300. 2009.PubMed/NCBI
17	Zhu SC, Li R, Wang YX, Feng W, Li J and Qiu R: Impact of simultaneous assay, the PCNA, cyclinD1, and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer-possible incorporation into clinical TNM staging system. World J Gastroenterol. 11:3823–3829. 2005.
18	Bandoh N, Ogino T, Katayama A, et al: HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis. Oncol Rep. 23:933–939. 2010. View Article : Google Scholar : PubMed/NCBI
19	Belicha-Villanueva A, Blickwedehl J, McEvoy S, Golding M, Gollnick SO and Bangia N: What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules? Immunol Res. 46:32–44. 2010. View Article : Google Scholar : PubMed/NCBI
20	Medina F, Ramos M, Iborra S, de Leon P, Rodriguez-Castro M and Del Val M: Furin-processed antigens targeted to the secretory route elicit functional TAP1−/−CD8+ T lymphocytes in vivo. J Immunol. 183:4639–4647. 2009.PubMed/NCBI
21	Herget M, Kreissig N, Kolbe C, Schölz C, Tampé R and Abele R: Purification and reconstitution of the antigen transport complex TAP: a prerequisite for determination of peptide stoichiometry and ATP hydrolysis. J Biol Chem. 284:33740–33749. 2009. View Article : Google Scholar : PubMed/NCBI
22	Atkins D, Ferrone S, Schmahl GE, Störkel S and Seliger B: Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma? J Urol. 171:885–889. 2004. View Article : Google Scholar : PubMed/NCBI
23	Seliger B, Atkins D, Bock M, et al: Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation. Clin Cancer Res. 9:1721–1727. 2003.